Assessment of myocardial viability in dysfunctional myocardium by resting myocardial blood flow determined with oxygen 15 water PET

Journal of Nuclear Cardiology

Volumn 10, Issue 1, 2003, Pages 34-45

  Nowak, Bernd ^a   Schaefer, Wolfgang M ^a   Koch, Karl Christian ^a   Kaiser, Hans Juergen ^a   Block, Stephan ^a   Knackstedt, Christian ^a   Zimny, Michael ^a   vom Dahl, Juergen ^a   Buell, Udalrich ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Myocardial blood flow; Myocardial hibernation; Myocardial viability; Oxygen 15 water; Position emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE; OXYGEN 15; TETROFOSMIN TC 99M; WATER;

ADULT; AGED; ARTICLE; ATTENUATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; FEMALE; HEART MUSCLE BLOOD FLOW; HEART MUSCLE REVASCULARIZATION; HUMAN; IMAGE ANALYSIS; MALE; MYOCARDIAL DISEASE; MYOCARDIAL HIBERNATION; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; VOLUMETRY;

EID: 0037228108     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1067/mnc.2003.128743     Document Type: Article

References (39)

1. Camici PG, Rimoldi O. Blood flow in myocardial hibernation. Curr Opin Cardiol 1998;13:409-14.
2. Diamond GA, Forrester JS, deLuz PL, Wyatt HL, Swan HJ. Post-extrasystolic potentiation of ischemic myocardium by atrial stimulation. Am Heart J 1978;95:204-9.
3. Rahimtoola SH. A perspective on the three large multicenter randomized clinical trials of coronary bypass surgery for chronic stable angina. Circulation 1985;72:V123-35.
4. Rahimtoola SH. The hibernating myocardium. Am Heart J 1989;117:211-21.
5. Tillisch J, Brunken R, Marshall R, Schwaiger M, Mandelkern M, Phelps M, et al. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med 1986;314:884-8.
6. Tamaki N, Yonekura Y, Yamashita K, Saji H, Magata Y, Senda M, et al. Positron emission tomography using fluorine-18 deoxyglucose in evaluation of coronary artery bypass grafting. Am J Cardiol 1989;64:860-5.
7. Lucignani G, Paolini G, Landoni C, Zuccari M, Paganelli G, Galli L, et al. Presurgical identification of hibernating myocardium by combined use of technetium-99m hexakis 2-methoxyisobutylisonitrile single photon emission tomography and fluorine-18 fluoro-2-deoxy-D-glucose positron emission tomography in patients with coronary artery disease. Eur J Nucl Med 1992;19:874-81.
8. vom Dahl J, Altehoefer C, Sheehan FH, Buechin P, Uebis R, Messmer BJ, et al. Recovery of regional left ventricular dysfunction after coronary revascularization. Impact of myocardial viability assessed by nuclear imaging and vessel patency at follow-up angiography. J Am Coll Cardiol 1996;28:948-58.
9. 13N-ammonia uptake in myocardial single cells indicating potential limitations in its applicability as a marker of myocardial blood flow. Circulation 1985;71:387-93.
10. Arbab AS, Koizumi K, Toyama K, Arai T, Araki T. Technetium-99m-tetrofosmin, technetium-99m-MIBI and thallium-201 uptake in rat myocardial cells. J Nucl Med 1998;39:266-71.
11. Kupferschlager J, Muller B, Schulz G, Kaiser HJ, Wagenknecht G, Bares R, et al. A method for combined scatter and attenuation correction without transmission measurement for myocardial SPECT with 99m-Tc binding [in German]. Nuklearmedizin 1997;36:56-64.
12. vom Dahl J, Altehoefer C, Sheehan FH, Buechin P, Schulz G, Schwarz ER, et al. Effect of myocardial viability assessed by technetium-99m-sestamibi SPECT and fluorine-18-FDG PET on clinical outcome in coronary artery disease. J Nucl Med 1997;38:742-8.
13. Kety S. Theory of blood-tissue exchange and its application to measurement of blood flow. Methods Med Res 1960;8:223-7.
14. Kety S. Measurement of local blood flow by the exchange of an inert, diffusible substance. Methods Med Res 1960;8:228-36.
15. 15O and dynamic positron-emission tomography. Strategy for quantification in relation to the partial-volume effect. Circulation 1988;78:104-15.
16. Iida H, Rhodes CG, de Silva R, Yamamoto Y, Araujo LI, Maseri A, et al. Myocardial tissue fraction - correction for partial volume effects and measure of tissue viability. J Nucl Med 1991;32:2169-75.
17. 15O]water estimates of perfusion with quantification of regional myocardial blood flow by microspheres. Circulation 1993;87:512-25.
18. Iida H, Rhodes CG, de Silva R, Araujo LI, Bloomfield PM, Lammertsma AA, et al. Use of the left ventricular time-activity curve as a noninvasive input function in dynamic oxygen-15-water positron emission tomography. J Nucl Med 1992;33:1669-77.
19. Metz CE, Herman BA, Roe CA. Statistical comparison of two ROC-curve estimates obtained from partially-paired datasets. Med Decis Making 1998;18:110-21.
20. Schwarz ER, Schaper J, vom Dahl J, Altehoefer C, Grohmann B, Schoendube F, et al. Myocyte degeneration and cell death in hibernating human myocardium. J Am Coll Cardiol 1996;27:1577-85.
21. Iida H, Takahashi A, Tamura Y, Ono Y, Lammertsma AA. Myocardial blood flow: comparison of oxygen-15-water bolus injection, slow infusion and oxygen-15-carbon dioxide slow inhalation. J Nucl Med 1995;36:78-85.
22. Panza JA, Dilsizian V, Curiel RV, Unger EF, Laurienzo JM, Kitsiou AN. Myocardial blood flow at rest and contractile reserve in patients with chronic coronary artery disease and left ventricular dysfunction. J Nucl Cardiol 1999;6:487-94.
23. Marinho NV, Keogh BE, Costa DC, Lammertsma AA, Ell PJ, Camici PG. Pathophysiology of chronic left ventricular dysfunction. New insights from the measurement of absolute myocardial blood flow and glucose utilization. Circulation 1996;93:737-44.
24. Gerber BL, Melin JA, Bol A, Labar D, Cogneau M, Michel C, et al. Nitrogen-13-ammonia and oxygen-15-water estimates of absolute myocardial perfusion in left ventricular ischemic dysfunction. J Nucl Med 1998;39:1655-62.
25. Braunwald E, Kloner RA. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation 1982;66:1146-49.
26. Shen YT, Vatner SF. Mechanism of impaired myocardial function during progressive coronary stenosis in conscious pigs. Hibernation versus stunning? Circ Res 1995;76:479-88.
27. Pagano D, Townend JN, Parums DV, Bonser RS, Camici PG. Hibernating myocardium: morphological correlates of inotropic stimulation and glucose uptake. Heart 2000;83:456-61.
28. Di Carli MF. Predicting improved function after myocardial revascularization. Curr Opin Cardiol 1998;13:415-24.
29. Gewirtz H, Fischman AJ, Abraham S, Gilson M, Strauss HW, Alpert NM. Positron emission tomographic measurements of absolute regional myocardial blood flow permits identification of nonviable myocardium in patients with chronic myocardial infarction. J Am Coll Cardiol 1994;23:851-9.
30. Grandin C, Wijns W, Melin JA, Bol A, Robert AR, Heyndrickx GR, et al. Delineation of myocardial viability with PET. J Nucl Med 1995;36:1543-52.
31. Gerber BL, Vanoverschelde JL, Bol A, Michel C, Labar D, Wijns W, et al. Myocardial blood flow, glucose uptake, and recruitment of inotropic reserve in chronic left ventricular ischemic dysfunction. Implications for the pathophysiology of chronic myocardial hibernation. Circulation 1996;94:651-59.
32. 11C-acetate and positron emission tomography. Threshold criteria of reversible dysfunction. Circulation 1997;95:1417-24.
33. Conversano A, Walsh JF, Geltman EM, Perez JE, Bergmann SR, Gropler RJ. Delineation of myocardial stunning and hibernation by positron emission tomography in advanced coronary artery disease. Am Heart J 1996;131:440-50.
34. 15O-water and dynamic positron emission tomography. Circulation 1992;86:167-78.
35. 15O-water-perfusable tissue fraction in experimental canine studies of old myocardial infarction. J Nucl Med 2000;41:1737-45.
36. Herrero P, Staudenherz A, Walsh JF, Gropler RJ, Bergmann SR. Heterogeneity of myocardial perfusion provides the physiological basis of perfusable tissue index. J Nucl Med 1995;36:320-7.
37. de Silva R, Yamamoto Y, Rhodes CG, Iida H, Nihoyannopoulos P, Davies GJ, et al. Preoperative prediction of the outcome of coronary revascularization using positron emission tomography. Circulation 1992;86:1738-42.
38. Vanoverschelde JL, Depre C, Gerber BL, Borgers M, Wijns W, Robert A, et al. Time course of functional recovery after coronary artery bypass graft surgery in patients with chronic left ventricular ischemic dysfunction. Am J Cardiol 2000;85:1432-9.
39. Bax JJ, Visser FC, Poldermans D, Elhendy A, Cornel JH, Boersma E, et al. Time course of functional recovery of stunned and hibernating segments after surgical revascularization. Circulation 2001;104:I314-1318.